Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Determinants of maximally attained level of pulmonary function.

Wang X, Mensinga TT, Schouten JP, Rijcken B, Weiss ST.

Am J Respir Crit Care Med. 2004 Apr 15;169(8):941-9.

PMID:
15072985
2.

Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study.

Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP.

Lancet. 2000 Oct 14;356(9238):1313-7.

PMID:
11073020
3.

Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample.

Hospers JJ, Schouten JP, Weiss ST, Postma DS, Rijcken B.

Epidemiology. 2000 May;11(3):261-8.

PMID:
10784241
4.
5.

Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample.

Hospers JJ, Schouten JP, Weiss ST, Rijcken B, Postma DS.

Am J Respir Crit Care Med. 1999 Dec;160(6):1869-74.

PMID:
10588599
6.

Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study.

Grol MH, Gerritsen J, Vonk JM, Schouten JP, Koëter GH, Rijcken B, Postma DS.

Am J Respir Crit Care Med. 1999 Dec;160(6):1830-7.

PMID:
10588593
7.

Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years.

Hospers JJ, Rijcken B, Schouten JP, Postma DS, Weiss ST.

Am J Epidemiol. 1999 Sep 1;150(5):482-91.

PMID:
10472948
8.

Wheezing in school children is not always asthma.

Nystad W, Stensrud T, Rijcken B, Hagen J, Magnus P, Carlsen KH.

Pediatr Allergy Immunol. 1999 Feb;10(1):58-65.

PMID:
10410919
9.

Smoking and airway hyperresponsiveness especially in the presence of blood eosinophilia increase the risk to develop respiratory symptoms: a 25-year follow-up study in the general adult population.

Jansen DF, Schouten JP, Vonk JM, Rijcken B, Timens W, Kraan J, Weiss ST, Postma DS.

Am J Respir Crit Care Med. 1999 Jul;160(1):259-64.

PMID:
10390409
10.

Risk factors from childhood to adulthood for bronchial responsiveness at age 32-42 yr.

Grol MH, Postma DS, Vonk JM, Schouten JP, Rijcken B, Koëter GH, Gerritsen J.

Am J Respir Crit Care Med. 1999 Jul;160(1):150-6.

PMID:
10390393
11.

Effects of ambient air pollution on upper and lower respiratory symptoms and peak expiratory flow in children.

Boezen HM, van der Zee SC, Postma DS, Vonk JM, Gerritsen J, Hoek G, Brunekreef B, Rijcken B, Schouten JP.

Lancet. 1999 Mar 13;353(9156):874-8.

PMID:
10093979
12.
13.

The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to symptomatic and asymptomatic airway hyperresponsiveness.

Jansen DF, Rijcken B, Schouten JP, Kraan J, Weiss ST, Timens W, Postma DS.

Am J Respir Crit Care Med. 1999 Mar;159(3):924-31.

PMID:
10051274
14.

Peak expiratory flow variability, bronchial responsiveness, and susceptibility to ambient air pollution in adults.

Boezen M, Schouten J, Rijcken B, Vonk J, Gerritsen J, van der Zee S, Hoek G, Brunekreef B, Postma D.

Am J Respir Crit Care Med. 1998 Dec;158(6):1848-54.

PMID:
9847277
15.

Breathlessness in elderly individuals is related to low lung function and reversibility of airway obstruction.

Boezen HM, Rijcken B, Schouten JP, Postma DS.

Eur Respir J. 1998 Oct;12(4):805-10.

16.

Occurrence of occupational asthma in aluminum potroom workers in relation to preventive measures.

Sorgdrager B, de Looff AJ, de Monchy JG, Pal TM, Dubois AE, Rijcken B.

Int Arch Occup Environ Health. 1998 Feb;71(1):53-9.

PMID:
9523250
17.

Lack of correlation between bronchoconstrictor response and bronchodilator response in a population-based study.

Douma WR, de Gooijer A, Rijcken B, Schouten JP, Koëter GH, Weiss ST, Postma DS.

Eur Respir J. 1997 Dec;10(12):2772-7.

18.

Doses and models in risk assessment analysis for bronchial hyperresponsiveness.

de Marco R, Bugiani M, Zanolin E, Verlato G, Rijcken B.

J Clin Epidemiol. 1998 Jan;51(1):19-28.

PMID:
9467631
19.

Decline of FEV1 by age and smoking status: facts, figures, and fallacies.

Kerstjens HA, Rijcken B, Schouten JP, Postma DS.

Thorax. 1997 Sep;52(9):820-7. Review. No abstract available.

20.

Airways responsiveness and development and remission of chronic respiratory symptoms in adults.

Xu X, Rijcken B, Schouten JP, Weiss ST.

Lancet. 1997 Nov 15;350(9089):1431-4.

PMID:
9371166
21.

(A)symptomatic bronchial hyper-responsiveness and asthma.

Jansen DF, Timens W, Kraan J, Rijcken B, Postma DS.

Respir Med. 1997 Mar;91(3):121-34. Review. No abstract available.

22.

ERS/ATS workshop on longitudinal analysis of pulmonary function data, Barcelona, September 1995.

Rijcken B, Schouten JP, Weiss ST, Ware JH.

Eur Respir J. 1997 Mar;10(3):758-63. No abstract available. Erratum in: Eur Respir J 1997 May;10(5):1197.

23.

Longitudinal analyses of airway responsiveness and pulmonary function decline.

Rijcken B, Weiss ST.

Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 2):S246-9. Review. No abstract available.

PMID:
8970396
25.

PEF variability, bronchial responsiveness and their relation to allergy markers in a random population (20-70 yr).

Boezen HM, Postma DS, Schouten JP, Kerstjens HA, Rijcken B.

Am J Respir Crit Care Med. 1996 Jul;154(1):30-5.

PMID:
8680695
26.

Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community-based population study. The Dutch ECRHS Group.

Droste JH, Kerhof M, de Monchy JG, Schouten JP, Rijcken B.

J Allergy Clin Immunol. 1996 Apr;97(4):922-32.

PMID:
8655887
27.

Evaluation of methacholine dose-response curves by linear and exponential mathematical models: goodness-of-fit and validity of extrapolation.

Verlato G, Cerveri I, Villani A, Pasquetto M, Ferrari M, Fanfulla F, Zanolin E, Rijcken B, de Marco R.

Eur Respir J. 1996 Mar;9(3):506-11.

28.

Interstitial cystitis in The Netherlands: prevalence, diagnostic criteria and therapeutic preferences.

Bade JJ, Rijcken B, Mensink HJ.

J Urol. 1995 Dec;154(6):2035-7; discussion 2037-8.

PMID:
7500452
29.

Comparing FEV1 in adults in two community-based studies.

Xu X, Weiss ST, Dockery DW, Schouten JP, Rijcken B.

Chest. 1995 Sep;108(3):656-62.

PMID:
7656612
30.

Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1.

Rijcken B, Schouten JP, Xu X, Rosner B, Weiss ST.

Am J Respir Crit Care Med. 1995 May;151(5):1377-82.

PMID:
7735588
31.

Use and safety of a shortened histamine challenge test in an occupational study.

Kremer AM, Pal TM, Oldenziel M, Kerkhof M, de Monchy JG, Rijcken B.

Eur Respir J. 1995 May;8(5):737-41.

32.

Age, period, and cohort effects on pulmonary function in a 24-year longitudinal study.

Xu X, Laird N, Dockery DW, Schouten JP, Rijcken B, Weiss ST.

Am J Epidemiol. 1995 Mar 15;141(6):554-66.

PMID:
7900723
33.

Relation between respiratory symptoms, pulmonary function and peak flow variability in adults.

Boezen HM, Schouten JP, Postma DS, Rijcken B.

Thorax. 1995 Feb;50(2):121-6.

34.

Chronic respiratory symptoms and airway responsiveness to methacholine are associated with eosinophilia in older men: the Normative Aging Study.

Annema JT, Sparrow D, O'Connor GT, Rijcken B, Koëter GH, Postma DS, Weiss ST.

Eur Respir J. 1995 Jan;8(1):62-9.

35.

Airway hyperresponsiveness in workers exposed to low levels of irritants.

Kremer AM, Pal TM, Schouten JP, Rijcken B.

Eur Respir J. 1995 Jan;8(1):53-61.

36.

Airway hyper-responsiveness and the prevalence of work-related symptoms in workers exposed to irritants.

Kremer AM, Pal TM, Boleij JS, Schouten JP, Rijcken B.

Am J Ind Med. 1994 Nov;26(5):655-69.

PMID:
7832213
37.
38.

Host factors and environmental determinants associated with skin test reactivity and eosinophilia in a community-based population study.

Mensinga TT, Schouten JP, Rijcken B, Weiss ST, van der Lende R.

Ann Epidemiol. 1994 Sep;4(5):382-92.

PMID:
7981846
39.

Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences.

Xu X, Weiss ST, Rijcken B, Schouten JP.

Eur Respir J. 1994 Jun;7(6):1056-61.

40.

Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up.

van Pelt W, Borsboom GJ, Rijcken B, Schouten JP, van Zomeren BC, Quanjer PH.

Am J Respir Crit Care Med. 1994 May;149(5):1218-26.

PMID:
8173762
41.

Airway hyperresponsiveness, prevalence of chronic respiratory symptoms, and lung function in workers exposed to irritants.

Kremer AM, Pal TM, Boleij JS, Schouten JP, Rijcken B.

Occup Environ Med. 1994 Jan;51(1):3-13.

42.

Long-term variability of bronchial responsiveness to histamine in a random population sample of adults.

Rijcken B, Schouten JP, Weiss ST, Rosner B, De Vries K, Van der Lende R.

Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):944-9.

PMID:
8214948
43.

Factors associated with bronchial responsiveness to histamine in a population sample of adults.

Rijcken B, Schouten JP, Mensinga TT, Weiss ST, De Vries K, Van der Lende R.

Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1447-53.

PMID:
8503555
44.

Measuring bronchial responsiveness in epidemiology.

Rijcken B, Schouten JP.

Eur Respir J. 1993 May;6(5):617-8. No abstract available.

PMID:
8519368
45.

Reproducibility of childhood respiratory symptom questions.

Brunekreef B, Groot B, Rijcken B, Hoek G, Steenbekkers A, de Boer A.

Eur Respir J. 1992 Sep;5(8):930-5.

PMID:
1426200
46.

Perception of airway obstruction in a random population sample. Relationship to airway hyperresponsiveness in the absence of respiratory symptoms.

Brand PL, Rijcken B, Schouten JP, Koëter GH, Weiss ST, Postma DS.

Am Rev Respir Dis. 1992 Aug;146(2):396-401.

PMID:
1489130
47.

Is it useful to distinguish between asthma and chronic obstructive pulmonary disease in respiratory epidemiology.

Rijcken B, Schouten JP, Rosner B, Weiss ST.

Am Rev Respir Dis. 1991 Jun;143(6):1456-7.

PMID:
2048837
48.

The relationship of eosinophilia and positive skin test reactivity to respiratory symptom prevalence in a community-based population study.

Mensinga TT, Schouten JP, Rijcken B, Weiss ST, Speizer FE, van der Lende R.

J Allergy Clin Immunol. 1990 Jul;86(1):99-107.

PMID:
2370392
49.

The distribution of bronchial responsiveness to histamine in symptomatic and in asymptomatic subjects. A population-based analysis of various indices of responsiveness.

Rijcken B, Schouten JP, Weiss ST, Meinesz AF, de Vries K, van der Lende R.

Am Rev Respir Dis. 1989 Sep;140(3):615-23.

PMID:
2675701
50.

Incidence of diseases of the lower respiratory tract in family practice and low level air pollution.

Kardaun JW, van der Maas PJ, Habbema JD, Leentvaar-Kuijpers A, Rijcken B.

Fam Pract. 1989 Jun;6(2):86-91.

PMID:
2787255

Supplemental Content

Loading ...
Support Center